This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Other. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Clayton J Nelsen: Innovator in Multiparticulate Pharmaceutical Delivery
Introduction
Clayton J Nelsen is an accomplished inventor based in Aurora, CO (US). He has made significant contributions to the field of pharmaceutical delivery systems, particularly through his innovative work on multiparticulate formulations.
Latest Patents
Nelsen holds a patent for a multiparticulate that includes pharmaceutical or probiotic active ingredients designed for delivery via a shelf-stable liquid dosage form. This patent describes various embodiments of modified-release multiparticulates, which can comprise a core that includes a pharmaceutical and/or probiotic agent. The core may also contain additional excipients or binders to aid in its creation. The multiparticulates feature one or more functional coatings that provide a modified-release profile of the active ingredients when administered orally. Additionally, a coating of hypromellose acetate succinate (HPMCAS) is applied to impart stability in aqueous acidic media. Suspensions that include these modified-release multiparticulates are also detailed in his patent.
Career Highlights
Throughout his career, Clayton J Nelsen has focused on advancing pharmaceutical technologies. His innovative approach to multiparticulate systems has the potential to enhance the efficacy and stability of drug delivery methods.
Collaborations
Nelsen has collaborated with notable professionals in the field, including Samuel Reinhold, III and Robert Niichel. These partnerships have contributed to the development and refinement of his innovative ideas.
Conclusion
Clayton J Nelsen's work in multiparticulate pharmaceutical delivery represents a significant advancement in the field. His innovative patent showcases the potential for improved drug delivery systems that can benefit patients and healthcare providers alike.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile